Tryptamine Therapeutics Ltd (ASX:TYP) Insider Jason Carroll Acquires 500,000 Shares of Stock

Tryptamine Therapeutics Ltd (ASX:TYPGet Free Report) insider Jason Carroll bought 500,000 shares of the business’s stock in a transaction on Thursday, May 30th. The shares were acquired at an average cost of A$0.02 ($0.02) per share, with a total value of A$12,000.00 ($8,053.69).

Tryptamine Therapeutics Stock Performance

Featured Articles

Receive News & Ratings for Tryptamine Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tryptamine Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.